The FDA has issued guidance on this issue - buyers using compounded GLP-1 medications should understand they're using a product in a different regulatory category than the medications studied in the major clinical trials
When glucagon pathways are activated, the body shifts toward catabolic metabolism, breaking down stored energy rather than seeking new energy from food
In response, brands like Hims & Hers and Eden have already announced that they will no longer offer certain compounded GLP-1s, and Ro dropped all compounded weight-loss options from its site (after striking a deal with Zepbound manufacturer Eli Lilly)
E., Peeters, A., Cartensen, B
Request and review the Certificate of Analysis (COA) to confirm the use of semaglutide base API
Asian adults have the lowest obesity rates in the U.S